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Abstract
Leigh syndrome is a rare progressive neurodegenerative, mitochondrial disorder of childhood with only a few
cases documented from India. The clinical presentation of Leigh syndrome is highly variable. However, in most
cases it presents as a progressive neurological disease with motor and intellectual developmental delay and signs
and symptoms of brain stem and/or basal ganglia involvement. Raised lactate levels in blood and/or cerebrospinal
fluid is noted. It is the neuroimaging, mainly the Magnetic Resonance Imaging showing characteristic symmetrical
necrotic lesions in the basal ganglia and/or brain stem that leads to the diagnosis. Here, we report a case of
7 months old female child presenting to us with status epilepticus, delayed developmental milestones and
regression of the achieved milestones suspected to be a case of neurodegenerative disorder, which on MRI was
diagnosed as Leigh syndrome.
Background
Leigh Syndrome [1], also termed as subacute necrotising
encephalopathy is a rare, inherited progressive neurode-
generative disorder with characteristic pathological fea-
tures usually presenting in infancy or early childhood. It
was first reported in 1951 by Denis Leigh [2], a British
neuropathologist, in a 7 month old infant that pro-
gressed rapidly and resulted in death over a 6-week per-
iod. Clinically, Leigh syndrome is characterized by
psychomotor delay or regression, muscular hypotonia,
brainstem signs (especially strabismus, nystagmus and
swallowing difficulties), ataxia, pyramidal signs, respira-
tory insufficiency, lactate acidemia and acute deteriora-
tion following common infections. In most cases,
dysfunction of the respiratory chain enzymes is respon-
sible for the disease. It may be due to defects in genes
for the pyruvate dehydrogenase complex, cytochrome-c
oxidase, ATP synthase subunit 6, or subunits of mito-
chondrial complex I. Patterns of inheritance include
X-linked recessive, autosomal recessive, and mitochon-
drial [3]. However the genetic cause of a number of
cases of Leigh syndrome remains unknown, despite the
presence of a specific biochemical defect in many of
them. Despite its considerable clinical, genetic and bio-
chemistry heterogeneity, the basic neuropathological
features in children affected are almost identical; which
are focal, bilateral, and symmetric necrotic lesions asso-
ciated with demyelination, vascular proliferation and
gliosis in the brainstem, diencephalon, basal ganglia, and
cerebellum [4]. It is possible to come to a diagnosis of
probable SNE during life on the basis of clinical signs
and symptoms, mode of inheritance, metabolic abnorm-
alities, and neuroimaging findings [5]. We report a rare
case which presented clinically as a neurodegenerative
disorder and diagnosed as Leigh syndrome on MRI.
Case Presentation
A 7 month old female child, 2
nd product of second
degree consanguineous marriage, with an uneventful
perinatal history presented to our hospital with status
epilepticus, delayed developmental milestones and
regression of the achieved milestones. On initial exami-
nation, she was unconscious (Glassgow Coma Scale-5)
and afebrile. Initial management aimed at controlling
the seizures with Diazepam (i.v., 0.3 mg/kg stat) and
Phenytoin (i.v., 20 mg/kg stat followed by 5 mg/kg per
12 hourly). Following control of seizures the child went
into decerebrate posturing. The raised intracranial ten-
sion was treated with Mannitol (i.v., 5 mg stat). Her
pulse was 154 beats per minute, respiratory rate 36
cycles per minute and blood pressure 84/46 mm Hg.
Her weight was 5 kg and height 62 cms. CNS examina-
tion showed increased tone in the lower limbs. Deep
* Correspondence: drpiyushkalakoti@gmail.com
2Rural Medical College, Loni, Maharashtra, India
Full list of author information is available at the end of the article
Shrikhande et al. Italian Journal of Pediatrics 2010, 36:62
http://www.ijponline.net/content/36/1/62 ITALIAN JOURNAL 
OF PEDIATRICS
© 2010 Shrikhande et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.tendon reflexes were exaggerated with bilateral Babinski
sign. Pupils were dilated and sluggishly reacting to light.
Fundus examination and visual evoked potentials were
normal. After an hour of admission, she became apnoeic
and was put on ventilator. The above clinical findings
were highly suggestive of a neurodegenerative disorder
and the patient was further investigated.
Routine haemogram revealed haemoglobin 8.8 gm%,
packed cell volume 28.6%, total leucocyte count 26,800
cells per mm
3 with marked neutrophilia (85%) and lym-
phocyte count 10%. Cerebrospinal fluid examination
showed 4 cells, all lymphocytes and normal sugar and
protein levels. CSF lactate was significantly raised (8.8
mmol/L). Gram and ZN staining of the CSF showed no
organism and pus cells. Serum lactate (6.8 mmol/L) and
creatinine kinase (320 U/L) levels were abnormally
raised. Liver function test showed mild derangement
with AST- 54 IU/L, ALT- 49 IU/L and ALP- 109 IU/L.
Renal function test was within normal limits. Arterial
blood gas analysis indicated metabolic acidosis. Blood
and urine cultures were negative. Magnetic Resonance
Imaging was done which showed bilateral, symmetrical
abnormal lesions in the basal ganglia, thalami, cerebral
peduncles, dorsal medulla and peri aqueductal grey mat-
ter which were hyperintense in T2W, FLAIR and DW
images (Figure 1A, B &1C). There were prominent
Figure 1 MRI Findings of Leigh Syndrome. A & B: T2W image showing bilateral symmetrical abnormal signal intensities, seen in cerebral
peduncles, dorsal medulla and peri aqueductal grey matter. C: T2W image showing bilateral symmetrical abnormal signal intensities, seen
involving basal ganglia and thalami. D: T2W image showing prominent extracerebral CSF spaces in fronto-temporo-parietal region on both sides
depicting signs of frontal atrophy
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region on both the sides and showed the similar signal
characteristics (Figure 1D). Frontal atrophy with myeli-
nation normal for age was noticed. Above radiological
findings on MRI established the clinical diagnosis of a
neurodegenerative disorder as Leigh syndrome.
Supportive therapy for the suspected mitochondrial
disorder was begun with intravenous Thiamine infu-
sions, Carnitine, alkali supplementation and oral coen-
zyme Q10(Ubiquinone). Over the next 2 days, she
improved clinically and was extubated. However, the
next few hours were critical, her conditions deteriorating
and she went into respiratory arrest requiring reintuba-
tion. She went into coma with GCS 4. Oculocephalic
reflex became absent. The patient eventually died 10
days after admission.
Discussion
Leigh’s disease or SNE is a rare progressive neurological
disorder of the childhood. The estimated prevalence of
Leigh Syndrome was 2.05 cases per 1, 00,000 [6]. The
preschool incidence of Leigh syndrome was 1 out of
32000 [7]. Age of onset of symptoms is usually less than
2 years (infantile form), but others may present in child-
hood (juvenile form) and unusually in adulthood. It pre-
sents early in life with psychomotor regression,
abnormal muscle tone, weakness, dystonia, brainstem
and cerebellar dysfunction (ataxia), visual loss, missed
milestones or regression of the achieved milestones,
tachypnea, and seizures [2,8,9]. Affected children usually
become symptomatic within the first year of life with
feeding difficulties, vomiting and failure to thrive [1].
Death usually occurs within a few years after onset of
symptoms, typically from progressive respiratory failure
[10,11]. Laboratory analysis shows metabolic acidosis
with elevated blood, CSF lactate, and pyruvate concen-
trations [8]. It is usually inherited in an autosomal reces-
sive fashion. The underlying defect can be at any of the
sites in the enzyme pathway for respiratory metabolism.
Associated mitochondrial enzyme deficiencies are those
of pyruvate carboxylase, pyruvate dehydrogenase, cyto-
chrome C oxidase, and Complex 1 (NAD-Coenzyme Q
Reductase) [8,10]. The diagnostic criteria are: (1) Pro-
gressive neurological disease with motor and intellectual
developmental delay; (2) Signs and symptoms of brain-
stem and/or basal ganglia disease; (3) Raised lactate
levels in blood and/or cerebrospinal fluid; (4) Character-
istic symmetric necrotic lesions in the basal ganglia and/
or brainstem [4].
Neuroimaging [8,12-15] plays an important role in
diagnosis of patients with Leigh syndrome. The most
characteristic neuro-radiological findings are bilateral,
symmetric focal hyperintensities in the basal ganglia,
thalamus, substantia nigra, and brainstem nuclei at
various levels on T2-weighted MRI. These high T2 sig-
nals on MRI reflect the spongiform changes and vacuo-
lation in the affected brain structures [16-18]. In the
basal ganglia, the putamen isp a r t i c u l a r l yi n v o l v e d .I n
one series, 100% of the patients with proven SNE had
putaminal involvement [8]. Ghosh and Pradhan [13]
reported two children with Leigh syndrome suspected
clinically and confirmed by MRI in 1996. Low attenua-
tion in the putamina on CT is considered to be charac-
teristic of the disease [11,19]. In India, Bhavsar VM,
Kumta NB [12] described the role of CT scan of the
brain in the diagnosis of Leigh syndrome in 1991. In
2004, Mannan and Sharma et al [20] reported autopsy
proven Leigh syndrome in a 15-month-old girl admitted
with cough and hyperventilation. In 2005, Hombal and
Narvekar [14] reported Leigh syndrome in a 3-year-old
child with regression of milestones and involuntary
movements. The diagnosis in their case was based on
neuroimaging.
Specific therapy for mitochondrial disorders in chil-
dren is not available. The results and prognosis are vari-
able. The aim of symptomatic treatment is to improve
the ATP production and to lower the lactate levels.
Thiamine, a cofactor of pyruvate dehydrogenase com-
plex has been reported to improve the neurological sta-
tus in some patients [21]. Marked improvement was
observed with riboflavin, which nearly normalized the
adenosine triphosphate production [22,23]. Rapid clini-
cal and biochemical improvement was observed in
patients with acute central respiratory failure with the
use of intravenous soya bean oil (ketogenic emulsion)
[24]. Ketogenic diet has been found to improve the out-
come in those with a deficiency of pyruvate dehydrogen-
ase [25]. Coenzyme Q and Carnitine [26] have also been
found to be effective. Leung TF, Hui J et al described
significant relief of dystonia with intramuscular botuli-
num toxin [27]. Nucleus transplantation into enucleated
oocyte is emerging as a new option for prevention of
mitochondrial disorders [28].
This child presented to us with seizures, regression of
developmental milestones and acute exacerbation caused
by a trivial respiratory illness. These symptoms pointed
towards a neurodegenerative disorder. Examination
revealed delayed development, hypertonia and disorien-
tation, all of which are recognized features of Leigh Syn-
drome [1]. CSF lactate was markedly elevated, but
arterial lactate was normal. Though Leigh Syndrome is
conventionally associated with elevated serum lactate,
earlier studies have shown that serum lactate can be
well within normal limits in spite of definite neuro-radi-
ological features and spectroscopic evidence of elevated
brain lactate [29]. The imaging findings suggested a pro-
gressive neurodegenerative disorder with the possibility
of a mitochondrial encephalopathy. This is consistent
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of Leigh Syndrome [8,12-15]. Enzymology, histology and
functional fibroblast ATP synthesis rate, molecular stu-
dies were not performed due to the paucity of facilities
and financial constraints.
Conclusion
The diagnosis of Leigh’s disease should be considered in
appropriate clinical and laboratory settings whenever
symmetrical hypodensities are encountered in the puta-
mina and midbrain on CT and further investigated with
MRI. Our experience suggested that bilateral symmetric
T2 prolongation involving multiple brainstem nuclei/
structures associated with basal ganglia abnormalities in
a child with neurological problems should prompt the
clinician to consider Leigh syndrome and conduct
further investigations such as measurement of blood
and/or CSF lactate, and respiratory chain enzymes activ-
ities. Neuro-sradiological discriminative observation is
very useful in guiding the clinicians for the most appro-
priate enzymatic and genetic study in their patients.
Mitochondrial disease cannot be cured completely.
Efforts for prevention and prenatal diagnosis are still in
the nascent stage. With appropriate investigations, accu-
rate diagnosis and prompt institution of adequate sup-
portive therapy, symptomatic amelioration can be
achieved, thereby adding life to the limited years of sur-
vival of these children. Further research aimed at prena-
tal identification of the responsible mutations and
prevention of the disease is warranted.
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